DrugSupplement
PAZ320 clinical trials
Also written PAZ320 and BTI320.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 1
Boston Therapeutics (6) · Chinese University of Hong Kong (1)
Related medicines
As reviewed, each with the page that says it.
- One of Hypoglycemic Agents source
Studies
Open first, then newest update. How each study uses PAZ320 is read from its arms, and is right about nine times in ten.
Testing it · 7
- The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic PatientsWithdrawnPhase 2Boston TherapeuticsNCT04569214Written as PAZ320
- Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 DiabetesCompletedPhase 2Boston TherapeuticsNCT03655535Written as BTI320
- Study of the Effectiveness and Safety of SugarDown vs. Placebo in Type 2 Diabetic Subjects Treated With MetforminCompletedNot applicableBoston TherapeuticsNCT02135549Written as SugarDown
- Determination of the PPG and Insulin Responses of Rice Alone and Rice Consumed With Sugardown™CompletedNot applicableBoston TherapeuticsNCT03375398Written as Rice
- Determination of the GI and II Values of Soft Drink and Soft Drink With Sugardown™CompletedNot applicableBoston TherapeuticsNCT03374501Written as Sugardown™
- BTI320 (SUGARDOWN®) on Post-Prandial Hyperglycaemia in Subjects With Pre-DiabetesCompletedPhase 2Chinese University of Hong KongNCT02358668Written as BTI320
- Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 DiabetesCompletedPhase 2Boston TherapeuticsNCT02060916Written as PAZ320
Codes
What other systems call PAZ320 · ClinicalTrials.gg INT000233
- MeSH (NLM) C000598421PAZ320One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000598421 | PAZ320 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.